Chris Hamby
@ChrisDHamby
Followers
6,399
Following
535
Media
131
Statuses
3,391
Investigative reporter @NYTimes. Author of Soul Full of Coal Dust, in stores and online now: https://t.co/BQffThH14M. D.C. resident. Nashville native.
Joined September 2010
Don't wanna be here? Send us removal request.
Tune in at 7 p.m.: Excited to be joining @adrianatrigiani
to discuss coal, black lung and my book, Soul Full of Coal Dust. https://t.co/uWLa3xJN4z
0
0
2
Chris Hamby Retweeted
SCOOP: Top Operation Warp Speed official warned last June that Emergent BioSolutions, whose plant ruined 15 million Covid vaccine doses, posed "key risks" & would have to be "monitored closely," says report obtained by @nytimes
w/@sharonlnyt @chrisdhamby
https://t.co/xZ0dPJHQNl
22
160
312
Last June, a top Operation Warp Speed official warned about inadequate staffing and quality control problems at the facility that recently had to toss up to 15M doses of Covid-19 vaccine because of contamination, a report obtained by @nytimes shows: https://t.co/RWXQbDs7sC
7
45
116
Chris Hamby Retweeted
NYT EXCLUSIVE: U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted @ChrisDHamby @SharonLNYT @SherylNYT https://t.co/0iXYIARfYH
1
7
9
Chris Hamby Retweeted
Officials with the firm, Emergent BioSolutions, claimed the mistake was an isolated incident, but our investigation found a pattern of lapses at the factory that suggests that the vaccine mix-up reflects deeper quality concerns. https://t.co/LCoFn2veCx https://t.co/hW5NslcpIz
33
440
1K
The company that had to scrap up to 15 million doses of Covid-19 vaccine last week, Emergent BioSolutions, was also the subject of our recent investigation into why the nation's emergency medical stockpile was ill-prepared for the pandemic. https://t.co/rEo8UpBL87
0
1
4
The U.S. bet big on Emergent BioSolutions to manufacture Covid-19 vaccines, but our examination found the company has flouted rules and downplayed errors at its Baltimore plant. So far, not a single dose has been deemed usable. w/@SherylNYT & @SharonLNYT
https://t.co/rOqeeWcOVf
1
5
4
Chris Hamby Retweeted
INVESTIGATION: The U.S. bet big on Emergent BioSolutions, the Maryland biotech whose Baltimore plant mixed up vaccine doses. Documents and internal audits obtained by @nytimes reveal a pattern of serious quality lapses. @ChrisDHamby @SharonLNYT & me.
https://t.co/DTpHPQrLH3
134
716
1K
Chris Hamby Retweeted
1
1
2
This @TB_Times investigation is a grim reminder of the often-unseen toll of occupational disease in the U.S.: https://t.co/DBVzqBr0Nj
1
3
5
White House press secretary Jen Psaki at today's briefing, when asked about our investigation of the nation's emergency medical reserve:
"The administration is going to undertake a comprehensive review and audit of the national stockpile.”
https://t.co/uQ5wGeMMoP
1
0
2
Chris Hamby Retweeted
President Biden on Monday canceled a visit to a coronavirus vaccine plant run by Emergent BioSolutions after The New York Times published an investigation into how the company gained outsize influence over the nation’s emergency medical reserve. https://t.co/FYkpjhRkRT
22
88
291
President Biden canceled his planned visit to the Emergent BioSolutions facility making coronavirus vaccines a day after our investigation into the company's tactics: https://t.co/uQ5wGeMMoP
@SherylNYT @nytimes
0
2
9
Chris Hamby Retweeted
A Maryland firm, Emergent BioSolutions, has used deep connections in DC to gain unrivaled dominance over the Strategic National Stockpile, which was woefully ill-prepared for the pandemic.
@ChrisDHamby and I investigated. Here's a look at the key players: https://t.co/iq2IomISMt
3
12
21
Chris Hamby Retweeted
The New York Times examined more than 40,000 pages of documents, some previously undisclosed, and interviewed more than 60 people with inside knowledge of the stockpile, revealing a deeply dysfunctional system that may have cost lives.
Read more: https://t.co/ucECf6KNix
14
152
323
Chris Hamby Retweeted
EXCLUSIVE: Why the Strategic National Stockpile was so ill-prepared for the pandemic. A well-connected biotech firm, Emergent BioSolutions, which now makes coronavirus vaccines, put an "extraordinary burden" on its budget.
@ChrisDHamby & I investigated.
https://t.co/kjLDzceBNy
54
385
588
Chris Hamby Retweeted
Throughout most of the last decade, the government has spent nearly half of the stockpile’s half-billion-dollar annual budget on anthrax vaccines, The New York Times found, leaving the country woefully unprepared for pandemic response. https://t.co/ucECf6KNix https://t.co/alB6mlwjD0
16
159
322
Chris Hamby Retweeted
Last year, as the pandemic raced across the country, the U.S. government paid Emergent $626 million for products that included vaccines to fight an entirely different threat: a terrorist attack using anthrax. https://t.co/ucECf6KNix https://t.co/XT2EmwaIA6
18
232
317
Chris Hamby Retweeted
Government purchases for the Strategic National Stockpile, the emergency medical reserve, have been influenced by the demands of biotech firms.
Chief among them is Emergent BioSolutions, a company now manufacturing coronavirus vaccines. https://t.co/ucECf6KNix https://t.co/vDuBna9Mmy
12
136
234